FDA Clears Trial for Wearable Hat Device to Treat Treatment-Resistant Depression
The FDA has approved an initial feasibility trial for a baseball cap-like device developed by Motif Neurotech. The device, which activates a brain imp...
Xeber.world
depression treatment
- electric vehicles
- automotive industry
- Stellantis
- collector cars
- automotive history
- Limited Edition
- classic cars
- Mecum Auctions
- supercar
- Formula 1
- Donald Trump
- AI ethics
- U.S. China relations
- AI adoption
- AI regulation
- artificial intelligence
- Trump administration
- inflation
- AI governance
- AI in business
- Bitcoin
- crypto regulation
- Senate Banking Committee
- CLARITY Act
- digital assets
- Digital Asset Market Clarity Act
- Federal Reserve
- Bitcoin price
- Bitcoin ETF
- crypto market
- AI cybersecurity
- cybersecurity
- CISA
- enterprise security
- CVE-2026-41089
- CVE-2026-41096
- Canvas data breach
- Instructure
- House Homeland Security Committee
- Donald Trump
- Netflix
- late-night TV
- Disney
- Paramount
- Cannes Film Festival
- Stephen Colbert
- Prime Video
- Jimmy Kimmel
- Marvel
- climate change
- renewable energy
- energy policy
- AI data centers
- geothermal energy
- Fervo Energy
- U.S. energy policy
- Strait of Hormuz
- Jason Bordoff
- Texas drought
- Subnautica 2
- Phasmophobia
- gaming news
- R.E.P.O.
- Forza Horizon 6
- FC 26
- Subnautica 2 tips
- Subnautica 2 guide
- Alan Wake event
- Destructoid
- FDA
- public health
- Marty Makary
- Trump administration
- healthcare policy
- Kyle Diamantas
- hantavirus
- health policy
- FDA leadership
- gene therapy
- Donald Trump
- Trump administration
- Supreme Court
- gerrymandering
- Iran war
- Voting Rights Act
- 2024 election
- Republican Party
- Virginia Supreme Court
- redistricting
- AI ethics
- climate change
- Elon Musk
- OpenAI
- ChatGPT
- tech industry
- Tesla
- remote sensing
- AI in the workplace
- generative AI
FDA Fast-Tracks Psilocybin and Methylone for Depression and PTSD Treatment
Six days after President Trump signed an executive order to expedite psychedelic drug reviews, the FDA issued national priority vouchers for psilocybi...
FDA Fast-Tracks Psychedelic Drugs for Depression: Potential Approval by Summer 2021
The FDA has granted expedited review to three experimental psychedelic drugs, including psilocybin for depression, under the Trump administration’s pr...
GLP-1 Drugs Such as Ozempic and Wegovy May Reduce Depression and Anxiety Risks, Study Finds
A large Swedish study published in The Lancet Psychiatry suggests GLP-1 receptor agonists like Ozempic and Wegovy may lower the risk of worsening depr...